15.98%| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 15.98 | 32.94 | -1.93 | 5.64 | NA |
| Classification | 15.90 | 34.15 | -3.64 | 2.15 | -1.27 |
| Index (S&P 500) | 23.50 | 48.80 | -5.90 | 0.70 | -0.90 |
| % Rank in Class (1-best,100=worst) | 43 | 50 | 32 | 14 | NA |
| Investment Objective: | Long/Short Equity |
|---|---|
| Net Assets ($Mil) | 936.00 |
| Inception Date: | 6/30/00 |
| Manager Name, Tenure | Bath/Bingaman/Dillon, 2002 / 2007 / 2000 |
| Expense Ratio: | 1.45% |
|
Sales Charge:
Load Type:
|
Front-End Load 5.00% 0.00% |
| Company Name | Symbol | % Net Assets |
|---|---|---|
| Jpmorgan 100% Us Treas Secs Mny Mkt Fund;capital | NA | 4.93 |
| Apache | APA | 4.65 |
| Occidental Petroleum Corp | OXY | 4.51 |
| Anadarko Petroleum Corp | APC | 4.49 |
| Devon Energy Corp | DVN | 3.41 |
| United Technologies Corp | UTX | 3.28 |
| Abbott Laboratories | ABT | 3.23 |
| Medtronic Inc | MDT | 3.22 |
| Procter & Gamble Co | PG | 3.20 |
| Jpmorgan Us Government Money Market Fund;capital | NA | 3.17 |
| % of Total Holdings | 38.09 | |